Kevin Amiri

Kevin Amiri, PhD, RAC, is a highly experienced regulatory affairs consultant with a career spanning over a decade in the pharmaceutical and biopharmaceutical industries. Currently serving as a Senior Regulatory Affairs Consultant at PAREXEL since May 2016, Kevin also provides regulatory consulting services at Validant and Pharmabiodevice. Kevin has a robust background in managing CMC regulatory changes for eCTD submissions and developing global filing strategies, with prior roles at notable companies including Sanofi, Pfizer, Merck, and Regeneron, where responsibilities included overseeing post-marketing CMC regulatory changes and ensuring compliance with health authority regulations. Kevin holds a Doctor of Philosophy (PhD) in Food Science and Technology from the University of Tennessee, Knoxville.